Positive Phase III results confirm Q2 2012 filing for Gilead's HIV drug booster, cobicistat
06 December 2011
Pial Ganguli
Please Login to read the full article.
06 December 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Gilead's HIV Quad meets primary endpoint, but not investors' expectations
- Gilead's 2nd positive Phase III sets up early FDA submission for Quad
- Nephrology-enhanced 'Quad' squad of FDA advisors backs Gilead's HIV combo
- Tibotec, Gilead in two potential deals for HIV combinations
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
